Grey’s Hospital unveils an advanced Philips cardiovascular X-ray system utilising augmented imaging for complex interventions

June 21, 2013

Pietermaritzburg, South Africa – Royal Philips (NYSE: PHG, AEX: PHIA), together with Grey’s Hospital, unveiled the Philips Allura Xper FD10/10 Biplane cardiovascular X-ray system today which caters to complex interventional cardiovascular procedures; providing exceptional visualisation of cardiac anatomy in examinations where contrast media and X-ray dose really matter.

 

“As the global market leader in interventional cardiology, we are proud to be continuing our partnership with Grey’s Hospital by providing them with the pioneering solutions incorporated in the Philips FD Biplane X-ray system," says Jose Fernandes, District Manager, Philips Healthcare Southern Africa.  "With augmented imaging capabilities, this new technological advancement is further evidence of our commitment to transforming healthcare in South Africa through best in class, minimally-invasive procedures."

 

Grey's hospital is a referral hospital, founded in 1855, and provides both regional and tertiary services in the Pietermaritzburg area. “We have been operating a predecessor system from Philips for the past 13 years, and were eager to work with a company that provides both reliable products and quality service again – Philips seemed the natural choice,” said xxx (from Grey’s Hospital).

 

Developed in partnership with paediatric cardiologists, the Philips FD Biplane’s low dose technology enables safe, superior image quality for a spectrum of patients being treated for congenital heart disease. Unique to this cardiovascular X-ray system, are the Xper Swing and StentBoost features.

 

The Xper Swing allows dual-axis rotational coronary angiography to gather more information in less time and with less X-ray and contrast dose. XperSwing acquires simultaneous RAO/LAO cranial-caudal views in just one acquisition run by moving the C-arm in a curved trajectory providing image detail required for diagnostic and therapeutic decisions and to obtain a real-time 3D impression of the coronary artery tree.

 

The StentBoost feature is a unique interventional tool to improve visualisation of stents in the coronary arteries during interventions. This exclusive and innovative interventional tool produces a highly augmented image of a deployed stent in coronary arteries in relation to the vessel lumen.

 

Philips’ Allura Xper FD10/10 Biplane cardiovascular X-ray system has been developed in response to a clear upward trend in the use of both X-ray imaging and 3D cardiac imaging during interventional procedures. “We look forward to offering our patients, at Grey’s Hospital, superior cardiovascular solutions with the introduction of Philips’ innovative technology,” concluded xxx (Grey’s Hospital). “In the dynamic field of complex cardiovascular interventions, the FD Biplane will be of tremendous value to the interventionalist, and in turn to the patient.”

For further information, please contact:

Nithasha Megnath
Marketing Manager
Philips Healthcare, Africa Region
Tel: +27 11 471 5260
E-mail: nithasha.megnath@philips.com.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 118,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter..